Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.

Klein v. Handley

Superior Court of Delaware, New Castle

July 31, 2013

KENNETH J. KLEIN, Plaintiff,
v.
MICHAEL K. HANDLEY, Defendant

DECISION AND JUDGMENTFOLLOWING TRIAL [1]

PAUL R. WALLACE, JUDGE

I. Introduction

Plaintiff Kenneth J. Klein instituted this action against his three former partners in Accelapure Corporation ("Accelapure"), Michael K. Handley, Terry A. Berger ("Berger"), and Robert J. Nairn ("Nairn"). The four men established Accelapure, a pharmaceutical compounding company, in 2005 and incorporated the company in Delaware. Mr. Klein claims that upon the dissolution of Accelapure, he shouldered a disproportionate share of its liability personally to clear outstanding debts -- including a bank loan and a deficient employee benefits plan -- through the sale of his personal property.

Prior to trial, Mr. Klein reached a settlement agreement with Berger and Nairn. Mr. Handley, who was pro se, [2] did not appear for the pretrial conference held in chambers on Friday, June 21, 2013. Although the Court attempted to contact Mr. Handley so he could participate in the conference by phone, Mr. Handley did not answer the phone number he provided.[3]Following the pretrial conference, the Court sent a letter to all counsel, including Mr. Handley, noting that the Court unsuccessfully attempted to contact Mr. Handley for the pretrial conference, that Mr. Handley was expected to fully participate as a pro se litigant, and that trial would not be delayed due to Mr. Handley's voluntary absence.

On Friday, July 19, 2013, the Court again phoned Mr. Handley to remind him that a bench trial in this matter was scheduled for July 22, 2013. Again unable to reach Mr. Handley, the Court, via the Civil Case Manager, sent an email to Mr. Handley with the trial information. That same day, at 7:52PM, Mr. Handley sent an e-mail response to the assigned Civil Case Manager informing her that he did not have the funds to appear in court or to hire an attorney and that he had recently sent the Court a letter explaining his situation. He offered to participate by phone, if the Court could accommodate him.

Mr. Handley did not appear on the morning of trial, July 22, 2013.[4]The Court, with opposing counsel present in the courtroom, again attempted to contact Mr. Handley via phone, again to no avail. Counsel for Mr. Klein opposed any continuance. The Court did not grant a continuance, but rather found that Mr. Handley had voluntarily absented himself from the proceedings by completely ignoring his obligations as a pro se litigant. Mr. Klein then presented his case to the Court, after which his counsel submitted Proposed Findings of Facts and Conclusions of Law.[5] This is the Court's decision following the abbreviated trial.

II. Factual and Procedural Background[6]

Accelapure was incorporated in 2004 to increase the speed of pharmaceutical development using purification technologies. From 2004 to 2007 the Board of Directors (the "Board") included Mr. Klein, Mr. Handley, Berger, and Nairn.[7] The Board appointed Mr. Handley as the Chief Executive Officer, Berger as President, Nairn as Vice President of Sales and Marketing, and Mr. Klein as the Vice President of Engineering and Operations. When the Board members established Accelapure, the company lacked necessary start-up capital. Thus, rather than purchase specialized laboratory equipment in Accelapure's name, Mr. Klein purchased the equipment under both his own name and the name of his personal S corporation, Klein Innovative Supply Service. Mr. Klein then entered into a lease agreement with Accelapure, whereby Accelapure would lease the laboratory equipment for $14, 467 per month for thirty-six months.[8]Accelapure defaulted on the lease with Mr. Klein in April 2006, after making eleven of thirty-six payments.

In 2005, Accelapure sought additional funding for its business through a $400, 000 commercial loan from Wilmington Trust Company. As a condition of the loan, Wilmington Trust required each of the four Board members to sign a personal guarantee.[9] A little more than a year later, additional attempts to raise capital had proven unsuccessful. As of September 2006, Accelapure was already about two months behind on its payments to Wilmington Trust with the delinquencies continuing thereafter. Accelapure's last payment to Wilmington Trust was in March 2007, when the remaining principal loan balance was approximately $335, 000. Wilmington Trust declared a default on the loan.

The next month, Mr. Klein began to sell the laboratory equipment to raise the necessary capital to satisfy the remaining Wilmington Trust loan balance. Mr. Klein first sold $330, 000 worth of equipment to Lotus Separations, a company comprised of former Accelapure employees. That $330, 000 was applied to and satisfied the remaining Wilmington Trust loan obligation. Of the $330, 000, Mr. Klein raised $248, 000 from the sale of his own equipment.

Accelapure also offered an employee-contributed 401(k) program as part of its employee benefits program. For each paycheck issued to an employee, Accelapure would withhold a certain amount that the company would then deposit in the employee's 401(k). As of May 2006, however, Accelapure discontinued those deposits into the 401(k) program even though it continued to withhold funds from employees' paychecks. In all, nine months of employee contributions totaling approximately $107, 000 were withheld from the 401(k) account.[10]

The advice of Accelapure's then legal counsel was that the Accelapure officers and directors would be personally liable for the 401(k) account deficiency. So Mr. Klein, on behalf of Accelapure, satisfied the $107, 000 short fall through the sale of $93, 100 of his equipment, including two mass spectrometers which sold for approximately $80, 000.

In the spring of 2007, Accelapure faced two lawsuits file by ex-employees, in addition to a Department of Labor judgment. Mr. Handley was personally named in each. In order to satisfy the $29, 000 levied across those three judgments, Mr. Klein sold additional laboratory equipment totaling approximately $20, 000.

In all, the sale of equipment owned by Mr. Klein satisfied $248, 000 of the Wilmington Trust loan debt, $93, 100 of the 401(k) deficiency, and $20, 000 of the three legal judgments against Accelapure. Mr. Handley did not contribute to the satisfaction of any of the obligations discussed herein. As he voluntarily absented himself from the ...


Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.